Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24

Showing 24 citing articles:

The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 22
Vaccine adjuvants: Tailoring innate recognition to send the right message
Ed C. Lavelle, Craig P. McEntee
Immunity (2024) Vol. 57, Iss. 4, pp. 772-789
Open Access | Times Cited: 18
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Sonja Fernbach, Nina K. Mair, Irène A. Abela, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 9
Open Access | Times Cited: 11
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
Adrian Gervais, Astrid Marchal, Andrea Fořtová, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 10
Open Access | Times Cited: 9
Human determinants of age-dependent patterns of death from infection
Laurent Abel, Jean‐Laurent Casanova
Immunity (2024) Vol. 57, Iss. 7, pp. 1457-1465
Open Access | Times Cited: 5
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Jérémie Rosain, Tom Le Voyer, Xian Liu, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 11
Open Access | Times Cited: 5
Life-threatening infections in human newborns: Reconciling age-specific vulnerability and interindividual variability
A. Borghesi
Cellular Immunology (2024) Vol. 397-398, pp. 104807-104807
Closed Access | Times Cited: 4
Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS‐CoV‐2‐Induced Immune Responses
Nicolle Rakanidis Machado, Beatriz Oliveira Fagundes, Lais Alves do Nascimento, et al.
Immunology (2025)
Closed Access
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design
Kevin Groen, Roger Kuratli, Jannik Enkelmann, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Open Access
Anti-cytokine autoantibodies in human susceptibility to infectious diseases: insights from Inborn errors of immunity
Kosuke Noma, Takaki Asano, Maki Taniguchi, et al.
Immunological Medicine (2025), pp. 1-17
Open Access
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
The past 25 years in paediatric rheumatology: insights from monogenic diseases
Seza Özen, Ivona Aksentijevich
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 585-593
Closed Access | Times Cited: 3
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
Adrian Gervais, Paul Bastard, Lucy Bizien, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 12
Open Access | Times Cited: 3
Longitudinal Analysis Over Decades Reveals the Development and Immune Implications of Type I Interferon Autoantibodies in an Aging Population
Sonja Fernbach, Nina K. Mair, Irène A. Abela, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Severe West Nile virus and Sars-CoV-2 infections in a patient with thymoma and anti-type I IFN antibodies
Federica Barzaghi, Camilla Visconti, Giovanni Battista Pipitone, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 2
A Novel Case of IFNAR1 Deficiency Identified a Common Canonical Splice Site Variant in DOCK8 in Western Polynesia: The Importance of Validating Variants of Unknown Significance in Under-Represented Ancestries
Aimee Huynh, Paul Gray, Anna Sullivan, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 2
Auto-immuno-deficiency syndromes
Gunnar Houen
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103610-103610
Closed Access | Times Cited: 2
A sensitive assay for measuring whole-blood responses to type I IFNs
Adrian Gervais, Corentin Le Floc’h, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access | Times Cited: 2
Monogenic Susceptibility to Infections With Viruses, Mycobacteria, Bacteria and Candida
Shen‐Ying Zhang, Jérémie Rosain, Capucine Pïcard, et al.
Elsevier eBooks (2024)
Closed Access
Molecular determinants of cross-species transmission in emerging viral infections
Arthur Wickenhagen, Sarah van Tol, Vincent J. Munster
Microbiology and Molecular Biology Reviews (2024) Vol. 88, Iss. 3
Closed Access
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children
Halima Kholaiq, Yousra Abdelmoumen, Abderrahmane Moundir, et al.
Clinical & Experimental Immunology (2024)
Closed Access
Interferon gene expression declines over time post-COVID infection and in long COVID patients
Alberto Gómez‐Carballa, Stefania Pischedda, Jacobo Pardo‐Seco, et al.
Infectious Diseases (2024) Vol. 57, Iss. 1, pp. 35-48
Open Access
Secondary infection after COVID-19
Tommaso Francesco Aiello, Mariana Chumbita, Patricia Monzó, et al.
European Respiratory Society eBooks (2024)
Closed Access
Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons
Valentine Le Stang, Paul Bastard, Elise Langouet, et al.
Journal of Clinical Immunology (2024) Vol. 45, Iss. 1
Closed Access
Page 1

Scroll to top